Bart Van Vooren advises clients on EU regulatory law and EU public policy with a particular focus on pharmaceuticals, devices, cosmetics, and food.
Mr. Van Vooren has particular expertise in the international dimension of EU law. This includes compliance within the EU with the Convention on Biological Diversity (Nagoya Protocol on access and benefit sharing of genetic resources) where he has developed unique experience in the pharmaceutical, food, cosmetics, and plant breeding sectors, spanning 21 jurisdictions: Australia, Belgium, Brazil, Canada, China, European Union, France, French Polynesia, Germany, India, Indonesia, Italy, Mexico, Singapore, South Africa, Spain, Switzerland, Thailand, the Netherlands, United Kingdom, and the United States.